Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation.
- Author:
Dan KE
1
;
Chun-xuan XU
;
Ya-zhou LIN
;
Jian-cheng ZHANG
;
Lin CHEN
;
Li-fang LIN
;
Xi-zhong HU
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Atrial Fibrillation; metabolism; pathology; Collagen Type I; genetics; Female; Fibrosis; Humans; Male; Matrix Metalloproteinase 2; genetics; Middle Aged; Myocardium; pathology; RNA, Messenger; analysis; Tissue Inhibitor of Metalloproteinase-2; genetics; Tissue Inhibitor of Metalloproteinases; genetics
- From: Chinese Journal of Cardiology 2005;33(5):459-463
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo determine the molecular mechanisms involved in atrial fibrosis which occurs in patients with atrial fibrillation (AF) and to investigate their effects on the initiation and maintenance of AF.
METHODSThe right atrial tissue samples were taken from 73 patients with rheumatic heart disease who underwent heart valve replacement surgery. 34 patients had no history of AF (sinus rhythm group), 9 patients had paroxysmal AF and 30 patients had persistent AF. The mRNA content of collagen type I, collagen type III, MMP-2, TIMP-1, TIMP-2, TIMP-3 and TIMP-4 was measured by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) and normalized to beta-actin or GAPDH.
RESULTSCompared to sinus rhythm group, the mRNA of collagen type I and MMP-2 increased significantly in the persistent AF group (all, P < 0.01), followed by the paroxysmal AF group (all, P < 0.05). The mRNA of collagen type III was slightly higher in both AF groups than in the sinus rhythm group, but the differences were not statistically significant (P > 0.05). The mRNA of TIMP-1, TIMP-2 and TIMP-3 was down-regulated in the persistent AF group (all, P < 0.01, respectively), however, the trends of reduction did not reach statistical significance in the paroxysmal AF group (P > 0.05). The mRNA of TIMP-4 remained compatible in each group. The mRNA of collagen type I was significantly correlated with left atrial dimension (r = 0.336, P = 0.004) and AF duration (r = 0.339, P = 0.003). The mRNA of MMP-2 was significantly correlated with the mRNA of TIMP-2 (r = -0.326, P = 0.006), the mRNA of collagen type I (r = 0.322, P = 0.006), left atrial dimension (r = 0.300, P = 0.011) and AF duration (r = 0.300, P = 0.010).
CONCLUSIONThe increased level of collagen type I associated with selective downregulation of TIMP-2 and upregulation of MMP-2 gene expression in atrium could be one of the molecular mechanisms of atrial fibrosis during atrial fibrillation, which correlates with the initiation and maintenance of AF.